Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Carcinoma × Aspirin × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 7 Colonic Neoplasms 6 Recurrence 4 Prostatic Neoplasms 4 Neoplasms 4 Polycythemia Vera 3 Venous Thromboembolism 2 Thrombocythemia, Essential 2 Rectal Neoplasms 2 Myocardial Infarction 2 Esophageal Neoplasms 2 Cardiovascular Diseases 2 Adenoma 2 Vascular Diseases 1 Thrombosis 1 Thrombocytopenia 1 Stomach Neoplasms 1 Primary Myelofibrosis 1 Precancerous Conditions 1 Pathologic Processes 1 Node Positive HER2 Negative Breast Cancer 1 Neoplasms by Site 1 Neoplasm Metastasis 1 Myocardial Ischemia 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Lynch syndrome I (site-specific colonic cancer) 1 Lymphoma, Follicular 1 Liver Cirrhosis 1 Ischemic Stroke 1

Interventions

Carboplatin 17 Cisplatin 14 Paclitaxel 12 Pemetrexed 11 pembrolizumab 9 Gemcitabine 7 Docetaxel 6 Sorafenib 5 osimertinib 4 durvalumab 4 130-nm albumin-bound paclitaxel 4 padeliporfin 3 cabozantinib 3 atezolizumab 3 Taxes 3 Radiotherapy 3 Mitomycin 3 Magnetic Resonance Spectroscopy 3 Cetuximab 3 Bevacizumab 3 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 3 trifluridine tipiracil drug combination 2 regorafenib 2 olaparib 2 Sunitinib 2 Specimen Handling 2 Radiotherapy, Intensity-Modulated 2 Radiation 2 Nivolumab 2 Irinotecan 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07529262 2026-04-14

AspiRe HCC

Curtin University

Phase 3 Not yet recruiting

Carcinoma, Fibrosis, Liver Cirrhosis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡